Apr 9, 2022 | Access, Featured
On this episode of the podcast, Terry and Bob discuss the access and affordability challenges that patients with Alzheimer’s and diabetes face. They highlight a new analysis that concludes an enormous $350 billion of prescription drug rebates were spent last...
Read more
Apr 9, 2022 | Access, Featured
WASHINGTON — Patients Rising Now Executive Director Terry Wilcox today released the following statement in response to CMS’ final decision to restrict access to FDA-approved Alzheimer’s treatments to clinical trial participants: “It’s a sad day for the millions...
Read more
Dec 30, 2021 | Access, Featured
In its second season, Patients Rising’s podcast has witnessed tremendous growth as we continue our coverage of topics that affect affordability and access to treatments and services, and dive into policy matters that regulate access and affordability. Here are a few...
Read more
Dec 10, 2021 | Access, Featured, Value Based Insurance Design
By Surabhi Dangi-Garimella, PhD Can health care services have low value? Turns out, they do! A service or a treatment that provides no or little benefit to the patient—or worse, might harm the patient—is a low-value service. While we might quickly jump to conclusions...
Read more
Oct 21, 2021 | Access, Health Insurance, Value Based Insurance Design
By Surabhi Dangi-Garimella, Ph.D. For more than a decade now, health plans have been modeling their benefit structure to encourage enrollees to use certain “high-value” services—whose clinical benefits supersede the cost—and discourage the use of “low value” services,...
Read more
Oct 11, 2021 | Access, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the latest on Congressional Democrats’ reconciliation bill, currently being debated, and explain provisions that will directly affect patients’ access to medications. Take the inclusion of H.R. 3, for...
Read more
